These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21122411)
1. [Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder]. Yang LP; Yang ZL; Tan XG; Miao XY Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):595-9. PubMed ID: 21122411 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder. Liu DC; Yang ZL Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106 [TBL] [Abstract][Full Text] [Related]
3. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. Xiong L; Yang Z; Yang L; Liu J; Miao X J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153 [TBL] [Abstract][Full Text] [Related]
4. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder]. Liu DC; Yang ZL Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571 [TBL] [Abstract][Full Text] [Related]
5. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder. Yang L; Lan S; Liu J; Yang Z Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336 [TBL] [Abstract][Full Text] [Related]
6. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder. Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Shu GS; Lv F; Yang ZL; Miao XY Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Shu GS; Yang ZL; Liu DC Pathol Res Pract; 2012 Jul; 208(7):392-7. PubMed ID: 22658478 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. Guzmán-Aránguez A; Olmo N; Turnay J; Lecona E; Pérez-Ramos P; López de Silanes I; Lizarbe MA J Cell Biochem; 2005 Jan; 94(1):178-93. PubMed ID: 15526283 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder. Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600 [TBL] [Abstract][Full Text] [Related]
11. Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance. Cai W; Li Q; Yang Z; Miao X; Wen Y; Huang S; Ouyang J Clin Transl Oncol; 2013 Oct; 15(10):818-24. PubMed ID: 23475628 [TBL] [Abstract][Full Text] [Related]
12. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Liu DC; Yang ZL; Jiang S Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766 [TBL] [Abstract][Full Text] [Related]
13. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions. Xiong L; Deng X; Wen Y; Yang Z; Miao X World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103 [TBL] [Abstract][Full Text] [Related]
14. Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. Zhu F; Xu C; Jiang Z; Jin M; Wang L; Zeng S; Teng L; Cao J Anat Rec (Hoboken); 2010 Aug; 293(8):1310-4. PubMed ID: 20665809 [TBL] [Abstract][Full Text] [Related]
15. Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations. Li Q; Yang Z J Exp Clin Cancer Res; 2009 May; 28(1):65. PubMed ID: 19445727 [TBL] [Abstract][Full Text] [Related]
16. [Analysis of diagnosis and treatment for 45 patients with gallbladder cancer]. Chen ZJ; Shi HQ; Song QT Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):475-6. PubMed ID: 21875493 [No Abstract] [Full Text] [Related]
17. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma. Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X Tumori; 2014; 100(6):667-74. PubMed ID: 25688501 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic features of gallbladder adenocarcinoma with marked stromal fibrosis--a report of 19 cases]. Wang YK; Zhao W; Hao Y; Zhang Y; Guo YB; Meng NL; Ma L; Li J Ai Zheng; 2006 Jul; 25(7):896-900. PubMed ID: 16831286 [TBL] [Abstract][Full Text] [Related]
19. Ornithine decarboxylase and glutamate decarboxylase 65 as prognostic markers of gallbladder malignancy: a clinicopathological study in benign and malignant lesions of the gallbladder. Deng X; Pei D Mol Med Rep; 2013 Feb; 7(2):413-8. PubMed ID: 23152127 [TBL] [Abstract][Full Text] [Related]
20. Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome. Li QL; Yang ZL; Liu JQ; Miao XY Pathol Oncol Res; 2011 Sep; 17(3):561-8. PubMed ID: 21221877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]